FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.4  |  FHIR Version n/a  User: [n/a]

773879000: Antineoplastic therapeutic role (role)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2019. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3726859011 Antineoplastic therapeutic role en Synonym Active Entire term case insensitive SNOMED CT core module
3726860018 Antineoplastic therapeutic role (role) en Fully specified name Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Antineoplastic therapeutic role Is a Therapeutic role true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Docetaxel 148mg/250ml in Sodium chloride 0.9% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Fluorouracil 1000mg/40ml solution for injection pre-filled syringes Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Doxorubicin 55mg/27.5ml solution for infusion pre-filled syringes Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Methotrexate 30mg/1.2ml solution for injection pre-filled syringes Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Methotrexate 750micrograms/5ml oral suspension Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Ingenol mebutate 500micrograms/g gel Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Fluorouracil 4450mg/300ml in Sodium chloride 0.9% infusion elastomeric devices Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Fluorouracil 7250mg/200ml in Sodium chloride 0.9% infusion elastomeric devices Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Interferon alfa-2a (rbe) 4.5million units/0.5ml solution for injection pre-filled syringes Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Methotrexate 25mg/0.5ml solution for injection pre-filled disposable devices Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Cisplatin 145mg/1000ml in Sodium chloride 0.9% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Gemcitabine 1.2g/120ml infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Temoporfin 20mg/5ml solution for injection vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Afatinib 30mg tablets Plays role False Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Methotrexate 5mg/5ml oral solution Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Methotrexate 15mg/0.3ml solution for injection pre-filled disposable devices Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Methotrexate 32.5mg/1.3ml solution for injection pre-filled syringes Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Vinorelbine 80mg capsules Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Idelalisib 100mg tablets Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Fluorouracil 2800mg/130ml in Sodium chloride 0.9% infusion elastomeric devices Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Methotrexate 200mg/8ml solution for injection vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Asparaginase 5,000unit powder for solution for injection vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Methotrexate 15mg/5ml oral solution Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Docetaxel 160mg/16ml solution for infusion vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Asparaginase 10,000unit powder for solution for infusion vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Megestrol 40mg/5ml oral suspension Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Cobimetinib 20mg tablets Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Carfilzomib 30mg powder for solution for infusion vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Bleomycin 15,000unit powder for solution for injection vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Carboplatin 330mg/500ml in Glucose 5% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Methotrexate 8mg/5ml oral solution Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Interferon alfa-2b (rbe) 18million units/3ml solution for injection vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Cyclophosphamide 1g/50ml solution for infusion pre-filled syringes Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Mercaptopurine 25mg tablets Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Imatinib 400mg capsules Plays role False Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Cyclophosphamide 1000mg/250ml in Sodium chloride 0.9% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Busulfan 2mg/5ml oral suspension Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Methotrexate 4mg/5ml oral suspension Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Cisplatin 164mg/1000ml in Sodium chloride 0.9% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Gemcitabine 1100mg/250ml in Sodium chloride 0.9% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Carboplatin 790mg/500ml in Glucose 5% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Cisplatin 36mg/250ml in Sodium chloride 0.9% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Peginterferon alfa-2a 90micrograms/0.5ml solution for injection pre-filled syringes Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Irinotecan 200mg/250ml in Sodium chloride 0.9% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Mitomycin 0.04% eye drops preservative free Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Fluorouracil 10mg/0.2ml solution for injection pre-filled syringes Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Fluorouracil 5000mg/120ml in Sodium chloride 0.9% infusion elastomeric devices Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Panitumumab 100mg/5ml solution for infusion vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Cyclophosphamide 50mg/5ml oral solution Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Methotrexate 10mg/5ml oral solution Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Peginterferon beta-1a 125micrograms/0.5ml solution for injection pre-filled disposable devices Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Methotrexate 20mg/0.8ml solution for injection pre-filled disposable devices Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Lenvatinib 4mg capsules Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Ponatinib 30mg tablets Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Vandetanib 100mg tablets Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Fulvestrant 250mg/5ml solution for injection pre-filled syringes Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Megestrol 20mg/5ml oral suspension Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Methotrexate 8mg/5ml oral suspension Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Docetaxel 80mg/2.88ml solution for infusion vials and diluent Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Cyclophosphamide 35mg/5ml oral suspension Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Mercaptopurine 20mg capsules Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Methotrexate 7.5mg/0.3ml solution for injection pre-filled syringes Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Vincristine 5mg/50ml in Sodium chloride 0.9% infusion bags Plays role False Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Cyclophosphamide 900mg/45ml solution for injection pre-filled syringes Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Methotrexate 1g/40ml solution for injection vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Methotrexate 25mg/3ml solution for injection pre-filled syringes Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Fluorouracil 2.5g/100ml solution for infusion vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Fluorouracil 4450mg/130ml in Sodium chloride 0.9% infusion elastomeric devices Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Everolimus 3mg dispersible tablets sugar free Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Melphalan 5mg tablets Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Temozolomide 180mg capsules Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Leuprorelin 3.75mg powder and solvent for suspension for injection vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Etoposide 500mg/25ml solution for injection vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Methotrexate 6mg/5ml oral suspension Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Carfilzomib 60mg powder for solution for infusion vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Mitoxantrone 30mg/15ml solution for injection vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Fluorouracil 3950mg/130ml in Sodium chloride 0.9% infusion elastomeric devices Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Methotrexate 1g/10ml solution for injection vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Carboplatin 400mg/500ml in Glucose 5% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Fluorouracil 5650mg/300ml in Sodium chloride 0.9% infusion elastomeric devices Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Fluorouracil 3500mg/105ml in Sodium chloride 0.9% infusion elastomeric devices Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Fluorouracil 1350mg/1000ml in Sodium chloride 0.9% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Irinotecan 360mg/250ml in Sodium chloride 0.9% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Nelarabine 250mg/50ml solution for injection vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Axitinib 1mg tablets Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Methotrexate 10mg/0.2ml solution for injection pre-filled disposable devices Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Busulfan 60mg/10ml solution for infusion vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Mercaptopurine 10mg tablets Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Triptorelin acetate 3mg powder and solvent for suspension for injection vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Megestrol 20mg capsules Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Carboplatin 560mg/500ml in Glucose 5% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Interferon alfa-2b (rbe) 30million units/1.2ml solution for injection pre-filled disposable devices Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Methotrexate 7.5mg/5ml oral suspension Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Bevacizumab 1% eye drops Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Cyclophosphamide 2000mg/250ml in Sodium chloride 0.9% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Pegaspargase 3,750unit powder for solution for injection vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Gemcitabine 1.6g/160ml infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Cyclophosphamide 500mg/25ml solution for injection pre-filled syringes Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Cyclophosphamide 100mg/5ml oral suspension Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Cyclophosphamide 4180mg/250ml in Sodium chloride 0.9% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Gemcitabine 200mg solution for infusion vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier

Start Previous Page 20 of 26 Next End

This concept is not in any reference sets

Back to Start